AI assistant
Sending…
NRX Pharmaceuticals, Inc. — Director's Dealing 2017
Dec 5, 2017
34346_dirs_2017-12-04_7c661aaf-2ea4-466f-a36c-1ea2309b0aa3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Big Rock Partners Acquisition Corp. (BRPAU)
CIK: 0001719406
Period of Report: 2017-11-20
Reporting Person: KIM BENNETT (N/A)
More from NRX Pharmaceuticals, Inc.
Capital/Financing Update
2026
Jun 4
Share Issue/Capital Change
2026
Jun 3
Capital/Financing Update
2026
Jun 2
Capital/Financing Update
2026
Jun 2
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Mar 23
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 23
Proxy Solicitation & Information Statement
2026
Feb 23
Regulatory Filings
2026
Feb 17